This question arises frequently as GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) become increasingly prescribed for type 2 diabetes and weight management
It is based on published clinical trial data, prescribing information from the MHRA-approved formulations, and practical pharmacy guidance
Your Treatment Plan Matters Avoiding common and serious side effects from any medications, including semaglutide, depends on your dosage, the specifics of your treatment plan, and your personal health history
In particular, they found that the activation of GLP-1R promoted the secretion of atrial natriuretic peptide (ANP) and lowered blood pressure
There are many theories about why some people fall into this category: Those with lower starting BMIs lose less weight
Further reading: Retatrutide dosage The long-term side effects of retatrutide are not fully known yet because the medicine is still being studied and has not been approved for routine use in the UK